sacituzumab govitecan
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of sacituzumab govitecan injection is restricted to patients in outpatient encounters or clinic use only (ie, no inpatient use)
Orders must be signed by a Hematology/Oncology Attending Physician
Use of sacituzumab govitecan injection is restricted to patients who meet the following criteria:
Med Center UNC Medical Center Formulary Restrictions
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of sacituzumab govitecan injection is restricted to patients in outpatient encounters or clinic use only (ie, no inpatient use)
Orders must be signed by a Hematology/Oncology Attending Physician
Use of sacituzumab govitecan injection is restricted to patients who meet the following criteria:
Med Center
UNC Medical Center Formulary Restrictions